1. Home
  2. THC vs VTRS Comparison

THC vs VTRS Comparison

Compare THC & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THC
  • VTRS
  • Stock Information
  • Founded
  • THC 1967
  • VTRS 1961
  • Country
  • THC United States
  • VTRS United States
  • Employees
  • THC N/A
  • VTRS N/A
  • Industry
  • THC Hospital/Nursing Management
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • THC Health Care
  • VTRS Health Care
  • Exchange
  • THC Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • THC 11.7B
  • VTRS 10.6B
  • IPO Year
  • THC N/A
  • VTRS N/A
  • Fundamental
  • Price
  • THC $175.03
  • VTRS $9.15
  • Analyst Decision
  • THC Buy
  • VTRS Hold
  • Analyst Count
  • THC 16
  • VTRS 5
  • Target Price
  • THC $186.94
  • VTRS $10.40
  • AVG Volume (30 Days)
  • THC 1.6M
  • VTRS 10.6M
  • Earning Date
  • THC 07-22-2025
  • VTRS 08-07-2025
  • Dividend Yield
  • THC N/A
  • VTRS 5.26%
  • EPS Growth
  • THC N/A
  • VTRS N/A
  • EPS
  • THC 15.09
  • VTRS N/A
  • Revenue
  • THC $20,520,000,000.00
  • VTRS $14,330,200,000.00
  • Revenue This Year
  • THC $2.24
  • VTRS N/A
  • Revenue Next Year
  • THC $4.99
  • VTRS $1.85
  • P/E Ratio
  • THC $11.64
  • VTRS N/A
  • Revenue Growth
  • THC N/A
  • VTRS N/A
  • 52 Week Low
  • THC $109.82
  • VTRS $6.85
  • 52 Week High
  • THC $178.76
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • THC 60.80
  • VTRS 54.81
  • Support Level
  • THC $169.03
  • VTRS $9.17
  • Resistance Level
  • THC $174.03
  • VTRS $9.39
  • Average True Range (ATR)
  • THC 4.18
  • VTRS 0.21
  • MACD
  • THC -0.40
  • VTRS 0.00
  • Stochastic Oscillator
  • THC 73.34
  • VTRS 63.82

About THC Tenet Healthcare Corporation

Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: